Prima Mente epigenetic foundation model scaling
Company: Nebius
The claim, verbatim
Prima Mente scaled Alzheimer's and Parkinson's epigenetic foundation model from 1B to 68B parameters on dedicated Nebius cluster
Source (primary)
nebius 8-K exhibit (tm2622968d1_ex99-2.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-09-01)Live source ↗
Quote: “Prima Mente scaled its Alzheimer's and Parkinson's epigenetic foundation model from 1 billion to 68 billion parameters on a dedicated Nebius cluster”
How we checked this
Checked on September 19, 2026. The cited source supports every part of this claim.
The document establishes all elements of the Prima Mente scaling claim.
Confirmed in the source:
- Prima Mente's epigenetic foundation model targets Alzheimer's and Parkinson's
- The model was scaled from 1 billion to 68 billion parameters
- Scaling occurred on a dedicated Nebius cluster
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1513845/000110465926094568/tm2622968d1_ex99-2.htm) in full (40,571 characters, retrieved September 1, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms nebius 8-K exhibit (tm2622968d1_ex99-2.htm)
Quote: “Prima Mente scaled its Alzheimer's and Parkinson's epigenetic foundation model from 1 billion to 68 billion parameters on a dedicated Nebius cluster”